CAMBRIDGE, Mass., Aug. 25, 2022 -- Aktis Oncology, a biotechnology company discovering and developing novel classes of targeted alpha radiopharmaceuticals to treat a broad range of solid tumors, today announced...
Panacos Attracts $18.3M Round To Fund HIV Drug Development (BioWorld Today)
News | 04. 16. 2008
Panacos Pharmaceuticals
Panacos Pharmaceuticals Inc. raised $18.3 million in its Series C round of financing.
